AHA GUIDELINES Bundle (free trial)

Chronic Coronary Disease 2023

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1504138

Contents of this Issue

Navigation

Page 21 of 65

22 Treatment Table 9. Substances With Abuse Potential and Adverse Cardiovascular Effects for Patients With CCD* Substance Potential Adverse Cardiovascular Effects Alcohol • J-shaped relationship between alcohol intake and cardiovascular risk in observational studies but limited by confounding. • Heavy alcohol use and binge drinking associated with increased morbidity and mortality rates. • May increase serum triglycerides. • Potential drug-drug interactions with cardiovascular therapies. Cocaine, methamphetamine • Stimulation of the sympathetic nervous system. • Platelet activation and aggregation. • Increased myocardial oxygen demand. • Can present with cocaine-associated chest pain. • MI risk independent of route of administration. Opioids • Possible association with risk of MI in chronic use. • High potential for dependence and abuse with chronic use. • Potential for drug-drug interactions with cardiovascular therapies. Marijuana • Stimulation of the sympathetic nervous system. • Platelet activation. • Endothelial dysfunction. • Carbon monoxide toxicity from smoking and inhalation. • Route of administration may impact toxicity, with edible products associated with fewer acute cardiovascular symptoms. * List is not all inclusive.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Chronic Coronary Disease 2023